Literature DB >> 3520561

Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor.

K Haranaka, E A Carswell, B D Williamson, J S Prendergast, N Satomi, L J Old.   

Abstract

Mouse tumor necrosis factor (TNF) was purified from serum through a series of steps, and each step was monitored for L-cell cytotoxicity in vitro and tumor-necrotizing activity in vivo. The two activities copurified and could not be dissociated. Purified mouse TNF has a specific activity of 2.2 X 10(7) (L-cell assay in the absence of actinomycin D) and 1 microgram causes necrosis of the standard TNF-sensitive sarcoma Meth A. TNF has a Mr of 39,000 +/- 2000 by gel filtration and a Mr of 16,000-18,000 by NaDodSO4/PAGE. Both molecular weight forms display cytotoxic and necrotizing activities. TNF has a pI of 3.9 and is destroyed by trypsin, protease, elastase, and alpha-chymotrypsin but not by neuraminidase or papain. These characteristics of nonrecombinant mouse TNF clearly resemble those of recombinant human and mouse TNF.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3520561      PMCID: PMC323642          DOI: 10.1073/pnas.83.11.3949

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse.

Authors:  S Green; A Dobrjansky; M A Chiasson; E Carswell; M K Schwartz; L J Old
Journal:  J Natl Cancer Inst       Date:  1977-11       Impact factor: 13.506

2.  Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization.

Authors:  B B Aggarwal; B Moffat; R N Harkins
Journal:  J Biol Chem       Date:  1984-01-10       Impact factor: 5.157

3.  Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).

Authors:  D N Männel; R N Moore; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

4.  Preliminary characterization of the tumor cell cytotoxin in tumor necrosis serum.

Authors:  F C Kull; P Cuatrecasas
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

5.  Research on the production site of tumor necrosis factor (TNF).

Authors:  N Satomi; K Haranaka; O Kunii
Journal:  Jpn J Exp Med       Date:  1981-12

6.  Murine tumor necrosis-inducing factor: purification and effects on myelomonocytic leukemia cells.

Authors:  S Green; A Dobrjansky; M A Chiasson
Journal:  J Natl Cancer Inst       Date:  1982-06       Impact factor: 13.506

7.  Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.

Authors:  B D Williamson; E A Carswell; B Y Rubin; J S Prendergast; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

Review 8.  Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture.

Authors:  L J Old
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

9.  Cytotoxic activity of tumor necrosis factor (TNF) on human cancer cells in vitro.

Authors:  K Haranaka; N Satomi
Journal:  Jpn J Exp Med       Date:  1981-06

10.  Tumour-necrosis factor from the rabbit. II. Production by monocytes.

Authors:  N Matthews
Journal:  Br J Cancer       Date:  1978-08       Impact factor: 7.640

View more
  20 in total

1.  Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.

Authors:  X M Sun; W Hsueh
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

2.  Tumor necrosis factor induces glomerular damage in the rabbit.

Authors:  T Bertani; M Abbate; C Zoja; D Corna; N Perico; P Ghezzi; G Remuzzi
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

3.  Degradation and inactivation of plasma tumor necrosis factor-alpha by pancreatic proteases in experimental acute pancreatitis.

Authors:  G Alsfasser; B Antoniu; S P Thayer; A L Warshaw; C Fernández-del Castillo
Journal:  Pancreatology       Date:  2005-03-15       Impact factor: 3.996

4.  Tristetraprolin mediates anti-inflammatory effects of nicotine in lipopolysaccharide-stimulated macrophages.

Authors:  Yeonsoo Joe; Hyo Jeong Kim; Sena Kim; Jiwha Chung; Myoung Seok Ko; Won Hyeok Lee; Ki Churl Chang; Jeong Woo Park; Hun Taeg Chung
Journal:  J Biol Chem       Date:  2011-05-23       Impact factor: 5.157

5.  Interrelationships between Infliximab and Recombinant Tumor Necrosis Factor-α in Plasma Using Minimal Physiologically Based Pharmacokinetic Models.

Authors:  Xi Chen; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Drug Metab Dispos       Date:  2017-04-14       Impact factor: 3.922

6.  Tumor necrosis factor mediates endotoxic effects in mice.

Authors:  F Bauss; W Dröge; D N Männel
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

7.  Alterations of bacterial clearance induced by endotoxin and tumor necrosis factor.

Authors:  T Koch; H P Duncker; R Axt; H G Schiefer; K van Ackern; H Neuhof
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

8.  Synergistic action of human recombinant tumor necrosis factor with endotoxins or nontoxic poly A:U against solid Meth A tumors in mice.

Authors:  N Bloksma; F M Hofhuis
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

9.  IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers.

Authors:  Bin Zhang; Theodore Karrison; Donald A Rowley; Hans Schreiber
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

10.  Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters.

Authors:  Patrycja Koszałka; Ewa Szmit; Andrzej Myśliwski; Jacek Bigda
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-07-23       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.